老年心脏病学杂志（英文版）2020，Vol.17Issue(11)：723-727,5.DOI:10.11909/j.issn.1671-5411.2020.11.010
Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?
Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?
Bei-Ning WANG 1Yu-Xi LI 2Wei MA 2Song-Yun CHU 2Zhi-Hao LIU 2Wen-Hui DING 2Jian-Ping LI3
作者信息
- 1. Department of Nephrology, Peking University First Hospital, Beijing, China
- 2. Department of Cardiology, Peking University First Hospital, Beijing, China
- 3. Key Laboratory of Molecular Cardiovascular Sciences of Ministry ofEducation, Health Science Center, Peking University, Beijing, China
- 折叠
摘要
关键词
Malignancy/Pericardial effusion/Pulmonary hypertension/Superior vena cava syndromeKey words
Malignancy/Pericardial effusion/Pulmonary hypertension/Superior vena cava syndrome引用本文复制引用
Bei-Ning WANG,Yu-Xi LI,Wei MA,Song-Yun CHU,Zhi-Hao LIU,Wen-Hui DING,Jian-Ping LI..Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?[J].老年心脏病学杂志（英文版）,2020,17(11):723-727,5.
